Merck | MRK - Market Capitalization


Merck reported $329.17B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 446.03B 61.34B Jul/2026
Abbott USD 175.87B 17.82B Jul/2026
ALKERMES USD 8.17B 562M Jul/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 197.73B 92.26B Jul/2026
Biogen USD 30.52B 1.38B Jul/2026
Bristol-Myers Squibb USD 131.55B 13.89B Jul/2026
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 2.41B 8.66B Jul/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 81.74B 1.6B Jul/2026
Glaxosmithkline GBP 108.55B 736M Jul/2026
J&J USD 602.98B 8.38B Jul/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 264.25B 23.66B Jul/2026
Novartis USD 319.89B 31.63B Jul/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Regeneron Pharmaceuticals USD 81.04B 15.67B Jul/2026
Roche Holding CHF 235.82B 34.18B Jul/2026
Sanofi EUR 93.07B 1.91B Jul/2026
Sanofi EUR 108.52B 5B Jul/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026